What the name refers to
An experimental selective androgen receptor modulator described mainly in preclinical research and patent literature.
Evidence and regulatory context
No broadly authorised human medicine is established for this entry. Published evidence may be preclinical, early-stage or sparse, and a research label is not a quality or safety certification.
Reading product records
Research-market surveys have repeatedly found label mismatches in this category. A record should therefore keep the claimed molecule, measured identity and measured amount separate, and should never treat the word “SARM” as evidence of approval or safety.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.